| __timestamp | Pfizer Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8393000000 | 15635076 |
| Thursday, January 1, 2015 | 7690000000 | 23943601 |
| Friday, January 1, 2016 | 7872000000 | 23689111 |
| Sunday, January 1, 2017 | 7657000000 | 41006114 |
| Monday, January 1, 2018 | 8006000000 | 51379106 |
| Tuesday, January 1, 2019 | 8650000000 | 32705593 |
| Wednesday, January 1, 2020 | 9405000000 | 53274000 |
| Friday, January 1, 2021 | 13829000000 | 85352000 |
| Saturday, January 1, 2022 | 11428000000 | 51999000 |
| Sunday, January 1, 2023 | 10679000000 | 59471000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. and Summit Therapeutics Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Pfizer's R&D expenses surged by approximately 27%, peaking in 2021 with a remarkable 13.8 billion dollars. This reflects Pfizer's robust strategy to maintain its leadership in the pharmaceutical industry. In contrast, Summit Therapeutics, a smaller player, increased its R&D spending by over 280% during the same period, albeit from a much smaller base, reaching a high of 85 million dollars in 2021. This significant growth underscores Summit's aggressive push to innovate and compete in niche markets. The data highlights the diverse strategies employed by pharmaceutical companies to drive innovation and secure their future in a competitive market.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Summit Therapeutics Inc.
Research and Development Expenses Breakdown: AbbVie Inc. vs Pfizer Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs GSK plc
Research and Development Expenses Breakdown: Pfizer Inc. vs Ascendis Pharma A/S
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Pfizer Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Taro Pharmaceutical Industries Ltd.